國立虎尾科技大學 |

Pharmacology of Itch

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pharmacology of Itch/ edited by Alan Cowan, Gil Yosipovitch.
其他作者:	Cowan, Alan.
面頁冊數:	VIII, 382 p. 42 illus., 34 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmacology. -
電子資源:	https://doi.org/10.1007/978-3-662-44605-8
ISBN:	9783662446058

Pharmacology of Itch
Pharmacology of Itch[electronic resource] /edited by Alan Cowan, Gil Yosipovitch. - 1st ed. 2015. - VIII, 382 p. 42 illus., 34 illus. in color.online resource. - Handbook of Experimental Pharmacology,2260171-2004 ;. - Handbook of Experimental Pharmacology,224.

Historical Background -- Epidemiology of the Burden of Chronic Itch -- Neurophysiology and Itch Pathways -- Brain Mechanisms of Chronic Itch -- Mouse and Human Models of Itch. Transient Receptor Potential Channels and Itch -- Cytokines and Itch -- Role of Mrgpr Family of Receptors and Itch -- Protease-activated Receptor Agonists and Itch -- VGLUT2-dependent Sensory Neurons and Itch -- Identification and Characterization of Spinal Inhibitory Neurons That Inhibit Itch -- Noradrenergic Itch Transmission in the Spinal Cord -- NK-1 Antagonists and Itch -- Cannabinoids and Itch -- Antihistamines and Itch -- Targeting Itch with Ligands Selective for k Opioid Receptors -- Neuraxial Opioid-induced Scratching and Its Pharmacological Antagonism -- Topical Therapies -- Allergic Itch in Dogs.

Basic research on the pharmacology of itch has exploded in the wake of two very influential papers that were published in Nature (2007) and Science (2009). Long overlooked as a milder form of pain, itching has rapidly gained a new appreciation in both research and clinical communities because of its complexity and its negative effects on the quality of life of the distressed patients. Like pain, not all itches are the same. Unlike pain, there are no standard drugs equivalent to aspirin and morphine. Epidemiological studies emphasize the high incidence and economic costs of itch (pruritus). It is the most prevalent symptom of a wide variety of allergic and inflammatory skin conditions (e.g., psoriasis, atopic dermatitis), is associated with several systemic diseases (e.g., chronic kidney and liver disease), and occurs in patients undergoing hemodialysis, spinal administration of opioids, and in those suffering from AIDS. The reader will learn about the multiple pathways for itch and their interactions with pain. The relationship between these closely related, yet distinct sensory phenomena, will be emphasized. Both itch and pain use several common molecules to send signals to the brain. Thus, drugs that have been, and are being, developed as analgesics may also attenuate intractable itch. This has been an exciting and very necessary turn of events since traditional H-1 receptor antagonists are ineffective in blocking the pruritus associated with kidney failure and cholestasis. The clinical chapters will provide insights into contemporary treatment regimens for pruritus in different human scenarios.

ISBN: 9783662446058

Standard No.: 10.1007/978-3-662-44605-8doiSubjects--Topical Terms:

583819
Pharmacology.

LC Class. No.: RM1-950

Dewey Class. No.: 615

Pharmacology of Itch
LDR:03844nam a22004095i 4500 001 969451
003 DE-He213
005 20200703022403.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783662446058 $9 978-3-662-44605-8
024 7 $a 10.1007/978-3-662-44605-8 $2 doi
035 $a 978-3-662-44605-8
050 4 $a RM1-950
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615 $2 23
245 1 0 $a Pharmacology of Itch $h [electronic resource] / $c edited by Alan Cowan, Gil Yosipovitch.
250 $a 1st ed. 2015.
264 1 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2015.
300 $a VIII, 382 p. 42 illus., 34 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 226
505 0 $a Historical Background -- Epidemiology of the Burden of Chronic Itch -- Neurophysiology and Itch Pathways -- Brain Mechanisms of Chronic Itch -- Mouse and Human Models of Itch. Transient Receptor Potential Channels and Itch -- Cytokines and Itch -- Role of Mrgpr Family of Receptors and Itch -- Protease-activated Receptor Agonists and Itch -- VGLUT2-dependent Sensory Neurons and Itch -- Identification and Characterization of Spinal Inhibitory Neurons That Inhibit Itch -- Noradrenergic Itch Transmission in the Spinal Cord -- NK-1 Antagonists and Itch -- Cannabinoids and Itch -- Antihistamines and Itch -- Targeting Itch with Ligands Selective for k Opioid Receptors -- Neuraxial Opioid-induced Scratching and Its Pharmacological Antagonism -- Topical Therapies -- Allergic Itch in Dogs.
520 $a Basic research on the pharmacology of itch has exploded in the wake of two very influential papers that were published in Nature (2007) and Science (2009). Long overlooked as a milder form of pain, itching has rapidly gained a new appreciation in both research and clinical communities because of its complexity and its negative effects on the quality of life of the distressed patients. Like pain, not all itches are the same. Unlike pain, there are no standard drugs equivalent to aspirin and morphine. Epidemiological studies emphasize the high incidence and economic costs of itch (pruritus). It is the most prevalent symptom of a wide variety of allergic and inflammatory skin conditions (e.g., psoriasis, atopic dermatitis), is associated with several systemic diseases (e.g., chronic kidney and liver disease), and occurs in patients undergoing hemodialysis, spinal administration of opioids, and in those suffering from AIDS. The reader will learn about the multiple pathways for itch and their interactions with pain. The relationship between these closely related, yet distinct sensory phenomena, will be emphasized. Both itch and pain use several common molecules to send signals to the brain. Thus, drugs that have been, and are being, developed as analgesics may also attenuate intractable itch. This has been an exciting and very necessary turn of events since traditional H-1 receptor antagonists are ineffective in blocking the pruritus associated with kidney failure and cholestasis. The clinical chapters will provide insights into contemporary treatment regimens for pruritus in different human scenarios.
650 0 $a Pharmacology. $3 583819
650 0 $a Anesthesiology. $3 645681
650 0 $a Dermatology. $3 669082
650 0 $a Pain medicine. $3 790323
650 0 $a Allergy. $3 645199
650 0 $a Immunology. $3 592892
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Pain Medicine. $3 669117
650 2 4 $a Allergology. $3 673940
700 1 $a Cowan, Alan. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1265014
700 1 $a Yosipovitch, Gil. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1265015
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783662446065
776 0 8 $i Printed edition: $z 9783662446041
776 0 8 $i Printed edition: $z 9783662512807
830 0 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 224 $3 1254015
856 4 0 $u https://doi.org/10.1007/978-3-662-44605-8
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)